The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Re-VOLVE: Phase II clinical trial in women with ovarian cancer progressing post-PARP inhibitor with treatment adapted to real-time assessment of evolving genomic resistance.
 
Pamela Soberanis Pina
No Relationships to Disclose
 
Amit Oza
Consulting or Advisory Role - Abbvie; AstraZeneca; MorphoSys; Senhwa Biosciences
Research Funding - Amgen (Inst); AstraZeneca (Inst); GlaxoSmithKline (Inst); Merck (Inst); Senhwa Biosciences (Inst)
(OPTIONAL) Uncompensated Relationships - Ozmosis Research
 
Neesha Dhani
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Knight Therapeutics; Merck
 
Lisa Wang
No Relationships to Disclose
 
Robert Grant
Consulting or Advisory Role - AstraZeneca; Eisai; Guardant Health; Incyte; Ipsen; Knight Therapeutics
Research Funding - Pfizer
 
Diane Provencher
Consulting or Advisory Role - Abbvie; AstraZeneca - Merck Alliance; Eisai; GlaxoSmithKline
Research Funding - Abbvie; AstraZeneca
 
Blaise Clarke
No Relationships to Disclose
 
Jean-Soo Lee
No Relationships to Disclose
 
Czin Czin Benito
No Relationships to Disclose
 
Fatima Selim
No Relationships to Disclose
 
Sahaj Arora
No Relationships to Disclose
 
Janelle Ramsahai
No Relationships to Disclose
 
Judy Quintos
No Relationships to Disclose
 
Prathuha Dhanabalan
No Relationships to Disclose
 
Valerie Bowering
No Relationships to Disclose
 
Bernard Lam
No Relationships to Disclose
 
Madhuran Thiagarajah
No Relationships to Disclose
 
Alexander Fortuna
No Relationships to Disclose
 
Trevor Pugh
No Relationships to Disclose
 
Stephanie Lheureux
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Merck; Roche/Genentech
Consulting or Advisory Role - Abbvie; AstraZeneca; Gilead Sciences; GlaxoSmithKline; Merck; Repare Therapeutics; Roche/Genentech; Seagen; Zai Lab
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Merck (Inst); Regeneron (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst); Schrodinger (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline (Inst)